Share on StockTwits

Neuralstem (NYSE:CUR) Insider Karl Johe unloaded 6,000 shares of Neuralstem stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $4.09, for a total transaction of $24,540.00. Following the transaction, the insider now directly owns 495,747 shares in the company, valued at approximately $2,027,605. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of Neuralstem (NYSE:CUR) traded up 1.07% during mid-day trading on Friday, hitting $3.78. 48,294 shares of the company’s stock traded hands. Neuralstem has a one year low of $1.65 and a one year high of $4.81. The stock has a 50-day moving average of $3.4 and a 200-day moving average of $3.77. The company’s market cap is $328.2 million.

Neuralstem (NYSE:CUR) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.03.

A number of analysts have recently weighed in on CUR shares. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Receive News & Ratings for Neuralstem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem and related companies with Analyst Ratings Network's FREE daily email newsletter.